Share-based compensation (Tables)
|
3 Months Ended |
Sep. 25, 2026 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Effect of Recording Share-Based Compensation Expense |
The effect of recording share-based compensation expense for the three months ended September 25, 2026 and September 26, 2025 was as follows: | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | (in thousands) | | | | | September 25,
2026 | | September 26,
2025 | | Share-based compensation expense by type of award: | | | | | | | | | Restricted share units | | | | | $ | 7,447 | | | $ | 6,368 | | | Performance share units | | | | | 3,778 | | | 2,703 | | | Total share-based compensation expense | | | | | 11,225 | | | 9,071 | | | Tax effect on share-based compensation expense | | | | | — | | | — | | | Net effect on share-based compensation expense | | | | | $ | 11,225 | | | $ | 9,071 | |
|
| Schedule of Share-Based Compensation Expense Recorded in Condensed Consolidated Statements of Operations and Comprehensive Income |
Share-based compensation expense was recorded in the unaudited condensed consolidated statements of operations and comprehensive income as follows: | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | (in thousands) | | | | | September 25,
2026 | | September 26,
2025 | | Cost of revenue | | | | | $ | 4,203 | | | $ | 3,519 | | | Selling, general and administrative expense | | | | | 7,022 | | | 5,552 | | | | | | | | | | | Total share-based compensation expense | | | | | $ | 11,225 | | | $ | 9,071 | |
|
| Schedule of Share-Based Payment Arrangement, Activity |
The following table summarizes the number of equity awards outstanding and ordinary shares available for grant under each of the Equity Incentive Plans as of September 25, 2026: | | | | | | | | | | | | | | | | | | | (share units) | Restricted Share Units outstanding | | Performance Share Units outstanding | | Ordinary Shares available for future grant | | 2020 Plan | 211,639 | | | 111,750 | | | 1,310,577 | | | 2017 Inducement Plan | — | | | — | | | 111,347 | | | Total | 211,639 | | | 111,750 | | | 1,421,924 | |
|
| Schedule of Restricted Share Unit Activity |
The following table summarizes restricted share unit activity under the Equity Incentive Plans: | | | | | | | | | | | | | Number
of
Shares | | Weighted-
Average Grant
Date Fair Value
Per Share | Balance as of June 26, 2026 | 211,574 | | | $ | 244.24 | | | Granted | 82,139 | | | $ | 444.87 | | | Vested | (78,776) | | | $ | 208.29 | | | Forfeited | (3,298) | | | $ | 352.61 | | Balance as of September 25, 2026 | 211,639 | | | $ | 333.80 | |
| | | | | | | | | | | | | Number
of
Shares | | Weighted-
Average Grant
Date Fair Value
Per Share | | Balance as of June 27, 2025 | 263,014 | | | $ | 187.00 | | | Granted | 67,584 | | | $ | 277.04 | | | Vested | (94,607) | | | $ | 162.08 | | | Forfeited | (3,801) | | | $ | 212.71 | | Balance as of September 26, 2025 | 232,190 | | | $ | 223.81 | |
|
| Schedule of Performance Share Unit Activity |
The following table summarizes performance share unit activity under the Equity Incentive Plans: | | | | | | | | | | | | | Number
of
Shares | | Weighted-
Average Grant
Date Fair Value
Per Share | Balance as of June 26, 2026 | 94,687 | | | $ | 269.67 | | | Granted | 62,944 | | | $ | 444.87 | | | Vested | (46,484) | | | $ | 261.84 | | | Forfeited | 603 | | | $ | 261.84 | | Balance as of September 25, 2026 | 111,750 | | | $ | 371.57 | |
| | | | | | | | | | | | | Number
of
Shares | | Weighted-
Average Grant
Date Fair Value
Per Share | | Balance as of June 27, 2025 | 120,916 | | | $ | 198.90 | | | Granted | 48,806 | | | $ | 277.04 | | | Vested | (73,936) | | | 158.91 | | | Forfeited | (2,943) | | | $ | 261.84 | | Balance as of September 26, 2025 | 92,843 | | | $ | 269.83 | |
|
| Schedule of Shared-Based Payment Fair Value Per Share Assumptions |
The grant date fair value of the Warrant was estimated as of the issuance date using the following assumptions: | | | | | | | | | | | Expected dividend yield | — | | | Risk-free interest rate | 3.8 | % | | Expected volatility | 45.2 | % | | Expected term (in years) | 7 years | | |
|